Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
X
X
Scientific presentation

Resolving tumor heterogeneity with single-cell co-detection of SNVs, CNVs, and immunophenotypes


Aaron Llanso
Description

Single-cell sequencing methods have enabled multi-modal characterization of tumor heterogeneity and yielded novel insights into tumor evolution, therapeutic response and resistance, and measurable residual disease (MRD). Aaron Llanson, DIrector of Market Development at Mission Bio, gives an overview of the Tapestri Platform and showcases the novel capability to co-detect SNVs, indels, CNVs, and immunophenotypes from the same cell with a single, high-throughput workflow. Single-cell multi-modal sequencing unlocks the ability to truly understand clonal architecture and resolve tumor heterogeneity.



VIEW


Scientific presentation
Introducing Europe to single-cell DNA sequencing
Gema Fuerte, MS
Mission Bio (2020)
Scientific presentation
Introducing Asia to single-cell DNA sequencing
Yue Wang, PhD
Mission Bio (2020)
Scientific presentation
How to detect DNA + Protein simultaneously in a single cell
Aik Ooi, PhD
Mission Bio (2020)
Scientific presentation
Agilent Technologies discusses the incorporation of targeted single-cell multi-omics to complement their product portfolio
Kevin Corcoran
Aaron Llanso
Agilent & Mission Bio (2020)
REQUEST QUOTE